Loading the section
Prices delayed by 15 minutes
The series is stated in the current share scale after splits; dividends are not included in the price
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| September 15, 2026 | 42.03 | 43.09 | 42.02 | 42.48 | 2m |
| September 14, 2026 | 42.92 | 42.94 | 41.74 | 41.88 | 2m |
| September 11, 2026 | 42.58 | 42.65 | 42.02 | 42.50 | 1m |
| September 10, 2026 | 42.00 | 42.63 |
Based on reports through December 31, 2025
Qiagen N.V. (QGEN) is a public company in the healthcare sector. Its common stock trade on NYSE.
Over the trailing twelve months as reported to 2025-12-31, revenue was 2.1bn $, net income was 424.9m $. Incorporated in NL.
This summary is compiled automatically from SEC filings and exchange data.
Address:HULSTERWEG 82, PL VENLO, 5912 PL
| 350m |
| TWSTTwist Bioscience Corporation | 157.26 | +9.92 % | 214m |
| HALOHalozyme Therapeutics, Inc. | 109.72 | +1.18 % | 211m |
| TECHBio-Techne Corp | 72.47 | +0.19 % | 186m |
| NBIXNeurocrine Biosciences, Inc. | 151.41 | +127.80 % | 173m |
| 41.89 |
| 42.13 |
| 1m |
| September 09, 2026 | 42.03 | 42.73 | 41.91 | 42.50 | 1m |
| September 08, 2026 | 42.40 | 42.74 | 42.22 | 42.38 | 2m |
| September 04, 2026 | 43.19 | 43.66 | 42.79 | 43.47 | 2m |
| September 03, 2026 | 44.41 | 44.46 | 43.16 | 43.86 | 2m |
| September 02, 2026 | 43.63 | 44.92 | 43.63 | 44.20 | 2m |
| September 01, 2026 | 44.23 | 44.32 | 43.08 | 43.39 | 3m |
| August 31, 2026 | 43.04 | 43.48 | 42.57 | 43.29 | 1m |
| August 28, 2026 | 43.62 | 43.99 | 42.99 | 43.11 | 1m |
| August 27, 2026 | 43.63 | 44.18 | 43.63 | 43.74 | 2m |
| August 26, 2026 | 43.37 | 43.87 | 43.23 | 43.36 | 2m |
| August 25, 2026 | 42.18 | 44.21 | 42.12 | 43.65 | 4m |
| August 24, 2026 | 43.95 | 44.06 | 41.42 | 41.78 | 9m |
| August 21, 2026 | 44.39 | 44.47 | 43.78 | 44.07 | 3m |
| August 20, 2026 | 44.21 | 45.53 | 44.20 | 44.90 | 5m |
| August 19, 2026 | 43.44 | 44.82 | 43.39 | 44.50 | 5m |
| August 18, 2026 | 43.06 | 43.46 | 42.32 | 42.32 | 3m |